Tiffany P. Olson — President of Nuclear Pharmacy Services at Cardinal Health

Ms. Tiffany P. Olson serves as President of Nuclear Pharmacy Services of Cardinal Health, Inc. Ms. Olson serves as President of Nuclear Pharmacy Services of Cardinal Health 414, LLC. Ms. Olson leads a network of 137 nuclear pharmacies and 37 positron emission tomography (PET) manufacturing sites that manufacture, compound, dispense and deliver more than 10 million patient doses annually. Prior to Cardinal Health, she served as President of NaviMed, a company focused on personalizing medicine through innovative diagnostics. She served as Vice President of Diagnostics at Eli Lilly and Company, where she led the strategy development effort to create and commercialize diagnostics. She spent more than 25 years in the medical diagnostics and healthcare industry. She served as the Head of North America Operations at Roche Diagnostics Corporation from June 1, 2005 to 2008 and its President until 2008. She served as Chief Executive Officer of Roche Diagnostics Corporation. She joined Roche Diagnostics in 1997. She served as the Global Head of Market Development located in Basel, Switzerland, leading Global Market Development for Roche Diagnostics Division of Basel, Switzerland. While in Switzerland, her responsibilities included Divisional Quality and Regulatory Management, Clinical Development, Government Affairs and Market Development. Ms. Olson was the Owner of Resource Consulting Services. She has 25 years of professional healthcare experience in healthcare industry. Her prior responsibilities at Roche Diagnostics include Vice President of Molecular Diagnostics, with responsibilities for sales, marketing and support for Roche's Molecular Diagnostics products in the U.S. She served as the Vice President of Corporate Accounts and Business Development Manager for Roche Diagnostics Corporation (USA) of Indianapolis Ind. She served as the Chairman and Member of Board of Advisors at Diaceutics Limited from November 15, 2011 to December 17, 2013. She has been a Director of Asuragen, Inc. since January 17, 2017. Ms. Olson served as an Independent Director of Ativa Medical Corporation. She served as a Director of Cesca Therapeutics Inc. from August 1, 2008 to March 31, 2010. She served as a Director of Central Indiana Corporate Partnership (CICP), Indiana's Governors Education Round Table, Women in Biotechnology, Exosome Diagnostics, Inc. and AdvaMed. She served a number of years in leading positions with other healthcare providers. She serves as a director at Community Health Network and Simon Youth Foundation. Ms. Olson holds an MBA from the University of St. Thomas (St.Paul, Minnesota) and a BS in Business from the University of Minnesota, School of Management.